| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.34B | 17.69B | 18.63B | 20.25B | 20.31B | 16.68B |
| Gross Profit | 10.42B | 9.04B | 11.79B | 13.87B | 14.12B | 10.21B |
| EBITDA | 12.96B | 10.66B | 11.93B | 13.84B | 13.99B | 10.55B |
| Net Income | 10.06B | 9.59B | 9.16B | 11.15B | 11.41B | 7.62B |
Balance Sheet | ||||||
| Total Assets | 245.09B | 244.31B | 249.95B | 241.45B | 224.64B | 235.04B |
| Cash, Cash Equivalents and Short-Term Investments | 12.36B | 3.68B | 1.10B | 5.56B | 3.09B | 987.62M |
| Total Debt | 105.50B | 106.50B | 111.50B | 104.50B | 93.00B | 105.60B |
| Total Liabilities | 120.15B | 120.70B | 125.30B | 118.64B | 105.10B | 119.51B |
| Stockholders Equity | 124.94B | 123.61B | 124.65B | 122.82B | 119.54B | 115.53B |
Cash Flow | ||||||
| Free Cash Flow | 18.36B | 18.02B | -4.15B | -1.87B | 23.68B | -9.22B |
| Operating Cash Flow | 19.89B | 19.44B | 13.78B | 19.54B | 53.14B | 11.77B |
| Investing Cash Flow | -1.68B | -1.34B | -17.30B | -20.27B | -30.95B | -20.29B |
| Financing Cash Flow | -11.76B | -15.63B | -330.60M | 3.60B | -20.00B | 6.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥234.79B | 21.34 | ― | 4.67% | 4.11% | 2.05% | |
73 Outperform | ¥664.45B | 10.14 | 5.51% | 4.64% | 24.10% | -30.38% | |
66 Neutral | ¥399.97B | 21.18 | 7.08% | 3.74% | 78.62% | 28.76% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥556.16B | 23.41 | 6.80% | 4.46% | 52.74% | 14.88% | |
63 Neutral | ¥260.05B | 11.18 | ― | 4.15% | -0.15% | -2.63% | |
62 Neutral | ¥192.27B | 9.62 | 7.82% | 3.87% | 21.72% | 5.02% |